Compare CDMOs specializing in biologics drug product formulation, aseptic fill-finish, and packaging for vials, syringes, and autoinjectors.
161 companies listed
Biologics drug product (DP) manufacturing transforms the purified drug substance into the final formulated, filled, and packaged product. This includes formulation optimization (excipient selection, concentration, pH, surfactant), sterile filtration, aseptic filling into primary containers, optional lyophilization, visual inspection, labeling, and secondary packaging.
Protein stability drives formulation complexity. Biologics are susceptible to aggregation, deamidation, oxidation, and fragmentation. The formulation must protect against these degradation pathways throughout the shelf life. CDMOs need scientists experienced in protein characterization and stability-indicating assay development.
Germany
Vetter Pharma is a leading global Contract Development and Manufacturing Organization specializing in aseptic fill-and-finish services for injectable drug products. Headquartered in Ravensburg, Germany, Vetter operates as an independent, family-owned business with over 75 years of experience.
Italy
AbbVie Contract Manufacturing is an embedded CMO within AbbVie, providing third-party contract manufacturing services for over 40 years across 12 locations in the US and Europe. They offer services spanning antibody drug conjugates, aseptic fill/finish, biologics (mAbs and derivatives), custom API, eye care, hot melt extrusion, HPAPI, and oral solid dose manufacturing.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.